$550,000 of SUNRUN INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Energy tax issues H.R.1 implementation"
You can find more data on corporate lobbying on Quiver Quantitative.
RUN Insider Trading Activity
RUN insiders have traded $RUN stock on the open market 34 times in the past 6 months. Of those trades, 1 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $RUN stock by insiders over the last 6 months:
- LYNN MICHELLE JURICH has made 0 purchases and 5 sales selling 100,954 shares for an estimated $1,849,763.
- JEANNA STEELE (Chief Legal & People Officer) has made 0 purchases and 9 sales selling 78,383 shares for an estimated $1,413,898.
- PAUL S. DICKSON (Pres. & Chief Revenue Officer) has made 0 purchases and 6 sales selling 59,275 shares for an estimated $1,069,986.
- EDWARD HARRIS FENSTER purchased 50,000 shares for an estimated $543,500
- MARY POWELL (Chief Executive Officer) has made 0 purchases and 6 sales selling 33,025 shares for an estimated $470,225.
- DANNY ABAJIAN (Chief Financial Officer) has made 0 purchases and 4 sales selling 21,748 shares for an estimated $321,568.
- ALAN FERBER sold 10,927 shares for an estimated $122,820
- MARIA BARAK (Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,993 shares for an estimated $30,105.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
RUN Hedge Fund Activity
We have seen 187 institutional investors add shares of RUN stock to their portfolio, and 188 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 10,239,545 shares (+2415.0%) to their portfolio in Q2 2025, for an estimated $83,759,478
- SYLEBRA CAPITAL LLC removed 8,273,331 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $67,675,847
- PGGM INVESTMENTS added 5,325,332 shares (+316.6%) to their portfolio in Q2 2025, for an estimated $43,561,215
- SOROS FUND MANAGEMENT LLC removed 5,189,486 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $42,449,995
- MAPLE ROCK CAPITAL PARTNERS INC. added 3,974,464 shares (+95.6%) to their portfolio in Q2 2025, for an estimated $32,511,115
- BLACKROCK, INC. removed 3,825,708 shares (-9.3%) from their portfolio in Q2 2025, for an estimated $31,294,291
- UBS GROUP AG removed 3,681,419 shares (-59.2%) from their portfolio in Q2 2025, for an estimated $30,114,007
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
RUN Analyst Ratings
Wall Street analysts have issued reports on $RUN in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 10/16/2025
- Susquehanna issued a "Positive" rating on 10/13/2025
- Goldman Sachs issued a "Buy" rating on 10/08/2025
- Jefferies issued a "Buy" rating on 10/01/2025
- Wells Fargo issued a "Overweight" rating on 08/14/2025
- UBS issued a "Buy" rating on 08/08/2025
- BMO Capital issued a "Underperform" rating on 08/07/2025
To track analyst ratings and price targets for RUN, check out Quiver Quantitative's $RUN forecast page.
RUN Price Targets
Multiple analysts have issued price targets for $RUN recently. We have seen 12 analysts offer price targets for $RUN in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Mark Strouse from JP Morgan set a target price of $25.0 on 10/16/2025
- Ameet Thakkar from BMO Capital set a target price of $19.0 on 10/15/2025
- Biju Perincheril from Susquehanna set a target price of $23.0 on 10/13/2025
- Brian Lee from Goldman Sachs set a target price of $21.0 on 10/08/2025
- Julien Dumoulin-Smith from Jefferies set a target price of $21.0 on 10/01/2025
- Christopher Dendrinos from RBC Capital set a target price of $16.0 on 08/18/2025
- Michael Blum from Wells Fargo set a target price of $14.0 on 08/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
